Article info

Download PDFPDF

Original article
SIGLEC1 is a biomarker of disease activity and indicates extraglandular manifestation in primary Sjögren's syndrome

Authors

  1. Correspondence to Professor Thomas Dörner, Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Charitéplatz 1—Berlin 10117, Germany; Thomas.Doerner{at}charite.de
View Full Text

Citation

Rose T, Szelinski F, Lisney A, et al
SIGLEC1 is a biomarker of disease activity and indicates extraglandular manifestation in primary Sjögren's syndrome

Publication history

  • Received April 5, 2016
  • Revision received October 22, 2016
  • Accepted November 1, 2016
  • First published December 30, 2016.
Online issue publication 
December 30, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.